Wenjing Zhao

Dr. Wenjing Zhao

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Journal of Genetics and Genomics
Verified
Journal Article
Closed access
WZWenjing Zhao
Wenjing Zhao
JTJieqiong Tan
Jieqiong Tan
TZTengfei Zhu
Tengfei Zhu
JOJianjun Ou
Jianjun Ou
YLYing Li
Ying Li
KXKun Xia
Kun Xia

23 November 2024 in Nucleic Acids Research
Verified
Journal Article
Open access
WZWenjing Zhao
Wenjing Zhao
YTYoufu Tao
Youfu Tao
JXJiayi Xiong
Jiayi Xiong
LLLei Liu
Lei Liu
ZWZhongqing Wang
Zhongqing Wang
Bin LiBin Li
Bin Li
Gain-of-function (GOF) variants, which introduce new or amplify protein functions, are essential for understanding disease mechanisms. Despite advances in genomics and functional research, identifying and analyzing pathogenic GOF variants remains challenging owing to fragmented data and database limitations, underscoring the difficulty in accessing critical genetic information. To address this challenge, we manually reviewed the literature, pinpointing 3089 single-nucleotide variants and 72 insertions and deletions in 579 genes associated with 1299 diseases from 2069 studies, and integrated these with the 3.5 million predicted GOF variants. Our approach is complemented by a proprietary scoring system that prioritizes GOF variants on the basis of the evidence supporting their GOF effects and provides predictive scores for variants that lack existing documentation. We then developed a database named GoFCards for general geneticists and clinicians to easily obtain GOF variants in humans (http://www.genemed.tech/gofcards). This database also contains data from >150 sources and offers comprehensive variant-level and gene-level annotations, with the aim of providing users with convenient access to detailed and relevant genetic information. Furthermore, GoFCards empowers users with limited bioinformatic skills to analyze and annotate genetic data, and prioritize GOF variants. GoFCards offers an efficient platform for interpreting GOF variants and thereby advancing genetic research.

9 September 2025 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
XPXiaoxia Peng
Xiaoxia Peng
XJXiangbin Jia
Xiangbin Jia
HWHanying Wang
Hanying Wang
JCJingjing Chen
Jingjing Chen
XZXiaolei Zhang
Xiaolei Zhang
HGHui Guo
Hui Guo
The Integrator complex plays essential roles in RNA polymerase II (RNAPII) transcription termination and RNA processing. Here, we identify INTS6, a subunit of the Integrator complex, as a novel gene associated with neurodevelopmental disorders (NDDs). Through analysis of large NDD cohorts and international collaborations, we identified 23 families harboring monoallelic likely gene-disruptive or de novo missense variants in INTS6. Phenotypic characterization revealed shared features, including language and motor delays, autism, intellectual disability, and sleep disturbances. Using a nervous-system conditional KO (cKO) mouse model, we show that Ints6 deficiency disrupts early neurogenesis, cortical lamination, and synaptic development. Ints6 cKO mice had a thickened ventricular zone/subventricular zone, thinning of the cortical plate, reduced neuronal differentiation, and increased apoptosis in cortical layer 6. Behavioral assessments of heterozygous mice revealed deficits in social novelty preference, spatial memory, and hyperactivity, mirroring phenotypes observed in individuals with INTS6 variants. Molecular analyses further revealed that INTS6 deficiency alters RNAPII dynamics, disrupts transcriptional regulation, and impairs synaptic gene expression. Treatment with a CDK9 inhibitor (CDK9i) reduced RNAPII phosphorylation, thereby limiting its binding to target genes. Notably, CDK9i reversed neurosphere overproliferation and rescued the abnormal dendritic spine phenotype caused by Ints6 deficiency. This work advances understanding of INTS-related NDD pathogenesis and highlights potential therapeutic targets for intervention.

25 June 2026 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
ZWZhongqing Wang
Zhongqing Wang
XCXin Chen
Xin Chen
ZCZiyun Cui
Ziyun Cui
XQXinyue Qi
Xinyue Qi
LGLi Gu
Li Gu
YJYan Jiang
Yan Jiang
Background: Pathogenic variants in MED13L , including copy‐number changes and sequence variants, cause MED13L syndrome. This rare neurodevelopmental disorder is characterized by global developmental delay, intellectual disability (ID), distinctive facial dysmorphism, hypotonia, and variable congenital heart defects. The phenotypic heterogeneity of MED13L syndrome underscores the significance of genotype–phenotype correlation analysis for improving clinical diagnosis and precise phenotypic characterization of affected individuals. Methods: Venous blood samples anticoagulated with EDTA were collected from the patient and family members, followed by whole‐exome sequencing analysis and subsequent validation using fluorescent quantitative PCR. Concurrently, a systematic search of the PubMed database was performed to summarize previously reported cases harboring MED13L copy number Variations (CNVs). Results: Whole‐exome sequencing revealed a de novo heterozygous single‐copy duplication of a ~19‐kb region within the MED13L gene (exons 8–16) in the proband. The patient presents phenotypic features consistent with MED13L syndrome and represents the first reported case exhibiting cleft lip. A literature review indicates that vision impairment, developmental delay, and congenital heart disease are widely observed phenotypes, while other less frequent manifestations vary between patients with duplications and deletions. Conclusion: This study, integrating a case report and a literature review, provides important reference evidence for the clinical genetic counseling of MED13L syndrome.